Prevention and treatment of Helicobacter pylori
Time of Update: 2023-01-05
08Is it checked every year?Professor Zhang Kai: If you are already an adult and positive, Helicobacter pylori will not be automatically cleared without treatment;If you receive treatment, you can take the test again after taking the medicine with an interval of more than 1 month, if not at that time, then more than 85% of people will not have it again for life.
THERMOLAST M - Can be overmolded on polyamide
Time of Update: 2022-11-17
Compliant with essential medical certifications such as ISO 10993-5 and -10, the MC/AD/PA series is an ideal material solution for medical grade plastic applications . Features of this range include e
A new cycle of medical device uplink
Time of Update: 2022-10-12
The fate of the three musketeers of the science and technology innovation board medical equipment heart pulse medical, huitai medical treatment, and nanwei medicine was once stifling. Innovation abil
Ma Qiulin, Vice Governor of Jiangsu Provincial People's Government, investigates food and drug supervision work
Time of Update: 2022-09-16
At present and in the future, we must conscientiously study and implement the spirit of the 19th National Congress of the Communist Party of China, insist on arming our minds and guiding practice with Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, and comprehensively improve the modernization level of food and drug safety management .
Following national policies closely, Jingxiaofu has deployed online medical insurance pilots to promote the integration of online and offline development
Time of Update: 2022-08-11
01 Keep up with national policies01 Follow national policies closely "Guiding Opinions on Medical Insurance Payment" , the opinion points out: Doing a good job in "Internet +" medical service medical
The most difficult collection in history: dental implants stuck in the "mouth
Time of Update: 2022-04-29
In February 2022, the relevant person in charge of the National Medical Insurance Bureau said: "In the first half of this year, we will strive to launch a coalition reform of the local centralized procurement of dental implants .
Five-year outlook: After the "three medical" data linkage, the national market will be unified and changed
Time of Update: 2022-01-09
, and unblock data sharing channels between departments, regions, and industries "Three-medicine linkage" big data application imagination and preparations for pharmaceutical companies Through the efforts of the "14th Five-Year Plan", the data of medical care, medical insurance and medicine has gradually improved standards and information processing specifications from decentralization and fragmentation, unified data structure and improvement of data transmission and storage.
In 2023, my country’s cardiovascular and cerebrovascular disease drug market will exceed 280 billion yuan
Time of Update: 2022-01-02
In the "Healthy China Action (2019-2030)", specific instructions were made on the prevention and treatment of cardiovascular and cerebrovascular diseases, and it was clearly necessary to promote the "three highs" co-management to carry out overweight and obesity, increased blood pressure and blood sugar, and dyslipidemia and other high-risk groups.
Gan Lai announced that the farnesol X receptor agonist ASC42 for the treatment of primary biliary cholangitis Phase II and III clinical trial protocol was approved by the China National Food and Drug
Time of Update: 2021-12-07
Based on the Phase II and Phase III clinical trial protocol of ASC42 for the treatment of PBC approved by the National Food and Drug Administration of China, Gan Lai will conduct phase II clinical trials in 100 patients with insufficient or intolerance to ursodeoxycholic acid (UDCA).
Tens of billions of antithrombotic drugs have fallen into the "Altar"! TOP10 rankings have changed, Yangzijiang and others will be the first to imitate
Time of Update: 2021-12-05
The 30 billion market makes waves againSales of Fondaparinux Sodium Injection in Public Medical Institutions in China (Unit: 100 million yuan)Source: Mi Nei. com, China's public medical institutions terminal competition patternA few days ago, Yangtze River Jiangsu Zilong Pharmaceutical's Fondaparinux Sodium Injection was approved as a supplementary application, and it is the fourth company that has reviewed the product .
In the first half of the year, the performance of the Chinese medicine sector was excellent, and the second half of the year continued to be optimistic
Time of Update: 2021-10-09
The industry believes that the outstanding performance of the Chinese medicine sector in the first half of the year was mainly due to the fact that frequent favorable policies + consumption attributes + valuation advantages constitute industry opportunities .
Out-of-hospital market breaks out, prescription circulation rules are released, injections are excluded
Time of Update: 2021-06-04
On May 24, the Hunan Provincial Health Commission, together with the Hunan Provincial Administration of Traditional Chinese Medicine and the Hunan Provincial Drug Administration, issued the "Notice o
Lancet Sub-Journal: Here comes the evidence-absolutely necessary
Time of Update: 2021-03-20
The study shows that investing in cancer treatment, imaging, and quality of care at the same time can produce huge health and economic benefits, especially in low- and middle-income countries.
Pharmaceutical Industry Investment Strategy 2017: Big Change Big Opportunities
Time of Update: 2021-02-07
focus on biopharmaceuticals and innovative pharmaceutical investment opportunities the blood products industry continues to recommend undervalued, pulping has a certain growth space of Hualan biology, Tiantan biology.
Guoxin Pharmaceutical Industry 2017 Portfolio A shares: Tonghua Dongbao, Huahai Pharmaceuticals, Hualan Bio, Kangmei Pharmaceuticals, China Resources 39, Lepu Medical, Changchun High-tech.
2020 China's health new power enterprise collection activities released Ted Pharmaceuticals won the title of new force enterprise in the chemical agent industry
Time of Update: 2021-01-03
2020 China's new health force enterprise collection activities awards are divided into ten, including "new power enterprises in the Chinese medicine industry", "new forces enterprises in the chemical